Huntington's disease (HD) is a neurodegenerative disease with currently only symptomatic treatment. Cell-based therapy, aiming at replacing the lost medium spiny neurons (MSN) with primary fetal striatal cells, has had some success at modifying the symptoms both in experimental studies and clinical trials. Additional pre-clinical studies are required to optimise transplantation protocols and conditions, learn about the limits of circuit reconstruction and functional recovery, and test alternative cell sources.
Introduction
Huntington's disease (HD) is an autosomal dominant progressive neurodegenerative disease with a defined genetic mutation in the huntingtin gene resulting in a pathologically extended trinucleotide CAG repeat. The clinical progression of the disease, including the early metabolic and cellular defects leading to neuronal loss, affects the caudate-putamen but infringes upon cortical areas as well, and leads to motor, cognitive, and psychiatric deficits (Walker, 2007) . Following the identification of the mutation (The Huntington's Disease Collaborative Research Group, 1993) , transgenic animal models have promoted understanding the aetiology of HD, and have contributed significantly to identifying potential therapeutic strategies that might lead to future cures. In parallel, non-transgenic, excitotoxic lesion models aiming to replicate the pathological neuronal loss -as opposed to the molecular and cellular pathogenesis -have been used to generate therapies to manage and to modify the disease progression. An important preclinical research strategy aimed at managing HD has been neuronal replacement therapy, and limited numbers of clinical trials of intrastriatal implantation of embryonic striatal tissue have been shown to have the potential to confer long-term benefits in patients with HD, although the benefits have been limited in terms of magnitude, duration and the number of patients to have benefited (Bachoud-Lévi et al., 2000 Bachoud-Lévi, 2009 ).
Striatal grafts typically establish new cortical, thalamic, serotonergic and dopaminergic afferents from the host, and can extend projections towards the normal striatal output targets (Wictorin, 1992) . However, the level of organisation of efferent projections re-established from striatal transplants is less well understood. Anatomical, tracing, and staining studies of normal connectivity have suggested two distinct projection pathways from the adult striatum: approximately half of the medial striatal spiny projection neurons (MSN) have dense efferent connections towards the external segment of the globus pallidus (GPe) and make up the so called 'indirect' pathway, whilst other striatal neurons send projections via the 'direct' pathway towards the pars reticulata of the 0165-0270/$ -see front matter © 2011 Elsevier B.V. All rights reserved. doi:10.1016/j.jneumeth.2011.01.015 substantia nigra (SNr) and the entopeduncular nucleus (EP) (Albin et al., 1989) . The two population of MSN are morphologically indistinguishable from each other, and are intermingled throughout the striasomes and matrix compartments of the striatum, but can be characterised by the presence of different receptor subtypes and peptides (Gerfen, 1992) . The two major striatal dopamine D1 and D2 receptor subtypes are predominantly located on MSNs giving rise to the direct and the indirect pathways, respectively, although there are collateral projections that suggest some overlap (Deng et al., 2006) . Furthermore, the muscarinic receptor M4 is selectively co-localized with the D1 receptor on MSNs of the direct pathway (Ince et al., 1997; Jeon et al., 2010) , giving those neurons a unique finger print.
To date there have not been any investigations examining the direct and indirect pathways in the context of striatal transplantation, principally due to the lack of appropriate experimental tools. Recent developments in the production of bacterial artificial chromosome (BAC) based transgenic mice have permitted the analysis of gene expression and function in the brain, which could not be accomplished using traditional methods (Lu, 2009; Valjent et al., 2009) . BAC mice express the green fluorescent protein (GFP) in a temporal and spatial specific manner depending on the regulatory elements engineered into the desired construct.
The BAC transgenic mouse line used in this study, expressing GFP under the control of the M4 promoter, is designed to selectively express the reporter gene in the direct efferent pathway of the MSN projecting from the striatum to the SNr and the EP. The current work aimed to validate the use of BAC-GFP animals as tissue donors in cell replacement therapy in a rodent model of HD by examining: (i) the effect of the transplantation procedure on the GFP expression; (ii) the feasibility of identifying the GFP expression in vivo after different time points; and (iii) the survival and integration of the transgenic striatal tissue transplant up to 6 months in the host. The data confirm that BAC transgenic animals expressing GFP under the M4 promoter in the striatonigral projection neurones represent a powerful novel way to study graft-host interaction in animal models of neurodegeneration.
Materials and methods

Re-derivation and establishing the transgenic colony
Sixteen frozen embryos from the Chrm4-EGFP transgenic line, referred to hereafter as M4-BAC-GFP, were purchased from the MMRRC (City, USA). The embryos were handled according to the appropriate protocol by members of the transgenic unit at the School of Biosciences, Cardiff (UK). All the embryos from the M4-BAC-GFP transgenic lines were implanted into a single surrogate CD1 strain female mouse, and 8 M4-BAC-GFP animals were born. The breeding scheme used by MMRRC to generate the re-derived frozen embryos relied on mating hemizygotes with wild type mice. Hemizygote mice carry one allele of one or more copies of the inserted construct at a given locus, hence, when bred with wildtype, approximately 50% of the litter carry the construct. Over the next two generations, selective breeding of GFP positive males and females ensured that a viable colony was established to produce appropriate breeding pairs to give rise to embryos that carried the GFP construct essential for the transplantation. During the study, the animals were kept in a temperature controlled room at 21 ± 2 • C, under a 12 h light/dark cycle. Food and water were available ad libitum.
Tail lysis and DNA extraction
Tail samples from the individual animals were prepared for genotyping using Lysis buffer (100 mM Tris-HCl pH 8.5, 5 mM EDTA pH 8.0, 0.2% SDS, 500 g/ml Proteinase K (Sigma P2308) in H 2 O, 200 mM NaCl). Tails were placed into 1.5 ml Eppendorf tubes and were incubated overnight at 55 • C in 500 l of the buffer. The next day, 500 l of phenol/chloroform/isoamylalcohol at a ratio of 25:24:1 was added, and transferred to Eppendorf Phase Lock tubes (prepared in advance by spinning at max speed for 1 min). The tubes were mixed but not vortexed and spun for 5 min at maximum speed and the supernatant transferred to a fresh tube. An equivalent volume of isopropanol was added, and the contents were well mixed, centrifuged at maximum speed for 5 min and the isopropanol removed. The remaining content was washed with 0.5 ml 70% EtOH, centrifuged at maximum speed for 5 min, and the 70% EtOH was removed. The DNA pellet was resuspended in 1 ml dH 2 O, incubated at 56 • C for 30 min to facilitate resuspension, and stored at 4 • C.
Genotyping of the animals
BIOTAQ TM Red DNA polymerase was used for the PCR analysis. Reactions were set-up using 1 l of genomic DNA, with the annealing temperature at 50 • C, and the cycle number at 29. The sequence of the primers used for the amplification of a segment of the GFP gene:
EGFP forward primer (#1): CACATGAAGCAGCACGACTT; EGFP reverse primer (#2): TGCTCAGGTAGTGGTTGTCG. The expected amplified product from the GFP gene was 379 bp.
Lesion of host animals and transplantation of M4-BAC embryonic tissue
Wild-type, 8 week old CD1 mice (n = 38; average weight 35 g) were used in the study. To induce the lesion, animals (n = 30) were anaesthetised by gas inhalation (Isoflurane, Abbott, UK; using O 2 and N 2 O as carrier gas) and placed in a stereotaxic frame (Kopf Instruments, Germany). Unilateral dorsal striatal lesions were made by injecting 0.50 l of 0.09 M quinolinic acid (Cambridge Research Biochemicals) dissolved in 0.1 M phosphate buffered saline, pH = 7.4, at each of the two depths in the left neostriatum. Each injection was carried out over a period of 3 min via a 30 gauge stainless steel cannula connected to a microdrive pump allowing 3 min for diffusion prior to withdrawal of the cannula. Injection coordinates were: A = 0.8; L = 2.0; V = −3.3/−2.7, with measurements in mm anterior (A) to the bregma, lateral (L) to the midline, vertical (V) below dura, and the nose bar set 0.0 mm below the interaural line. Before regaining consciousness, animals received 2.5 ml glucose saline s.c. and 0.05 ml diazepam (Roche, UK; 5 mg/ml) i.m. Paracetemol analgesic (1 g/l) was added to the drinking water commencing on the day before and continuing for 48 h after surgery. The lesioned animals were allowed 10 days of recovery prior to the transplantation procedure.
To generate the GFP positive embryonic tissue for grafting, pairs of confirmed GFP carrying homozygote males and females were housed together overnight from 16:00 h to 08:00 h the next day. The females were plug-checked to confirm mating, and the embryos harvested 14 days later (i.e. E14, with the day when mating was initiated as denoted as day zero). Graft tissue was dissected from the developing whole ganglionic eminence (WGE), incubated in trypsin, washed and prepared as dissociated cell suspensions as previously described (Fricker et al., 1996) . Tissue collected from 32 M4-BAC embryos was pooled. Cell viability was assessed by trypan blue exclusion in a haemocytometer, and showed to be 98%. Lesioned animals were anaesthetised and positioned in the stereotaxic frames (n = 24). The cell suspension was made up to 150,000 cells/l and injected via a 10 l microsyringe with a metal cannula (26 gauge, SGE, Australia) targeted at A = +0.8; L = +2.0; V= −3.2/−2.8 mm, with the nose bar set 0.0 mm below the interaural line. A volume of 1 l was injected over a period of 2 min at each of the two depths (total volume 2 l, 300,000 cells/graft), waiting 3 min for diffusion before retraction of the cannula, cleaning the wound, and suturing. Post-operative antibiotics and analgesia was administered as for the preceding lesion surgery.
Visualisation of the GFP positive transplants: fluorescent microscopy and immunohistochemistry
To confirm the presence of the reporter gene in the M4-BAC controls, and the grafted wild-type animals, both immunohistochemistry (IHC) and endogenous fluorophore properties of the GFP protein were exploited in freshly cut sections.
Grafted animals were sacrificed after either 12 or 24 (each n = 12) weeks post-grafting. Mice were anaesthetised with a 1 ml lethal dose of Euthatal (pentobarbital sodium, Vericore Ltd., Dundee, UK) and transcardially perfused with 75 ml 0.9% saline followed by 150 ml 4% paraformaldehyde in 0.1 M phosphate buffered saline (PBS). The brains were removed and post-fixed in 4% paraformaldehyde for 2 h, then immersed in 30% sucrose in PBS for minimum of 48 h. The tissue was serially sectioned at 40 m on a freezing stage microtome. Using free floating sections and the streptavidin-biotin method (DAKO) with 3,3 -diaminobenzidine as chromogen, 1:6 series of sections were stained for GFP, to identify the grafted tissue (Invitrogen, 1/1000); NeuN, a marker of mature neurones (1:4000; Sigma, UK); and DARPP-32, the dopamine and adenosine 3 :5monophosphate regulated phosphoprotein, used to identify striatal tissue (1:30,000; donated by Prof. H.C. Hemmings, Cornell University, USA). The stained sections were mounted on gelatinised slides, air dried, immersed into increasing concentrations of ethanol, and finally xylene, prior to cover slipping. An additional 1 in 6 series of sections were mounted onto slides and air dried overnight at room temperature for Nissl staining with Cresyl Violet to visual cell bodies. The stained sections were dehydrated and cover slipped.
Results
GFP expression in the adult M4-BAC transgenic mice
Immunohistochemical staining using a GFP primary antibody was used to confirm expression of the reporter gene and reveal the spatial location of the M4-BAC-GFP positive neurones in 3 month old transgenic mice. The observed GFP expression conformed with the expected pattern for the sub-type of MSN projecting via the direct pathway to SNr and EP (Fig. 1A) . GFP expression in the external segment of the globus pallidus (GPe) -a target nucleus for the indirect striatal projection neurones -was not apparent. Higher magnification revealed the staining to be specific to both the cell bodies, and the cellular processes including axonal projections ( Fig. 1B) . Sections from wild-type litter mates did not express GFP at any detectable level (Fig. 1C) .
GFP expression was also visualized in unfixed, freshly cut tissue sections obtained from 3 month old M4-BAC transgenic mice. Under ultraviolet illumination, GFP fluorescence was exploited and the observed distribution of the reporter protein supported what was previously seen using the immunohistochemical method. Strong fluorescent signal from cell bodies and their projections were observed in the striatum ( Fig. 2A and B) . The projections leaving the striatum towards the EP (Fig. 2C-E) , and projecting beyond the EP towards the SNr (Fig. 2F) were clearly identified. Overall, the data suggests that the actual expression pattern in the adult M4-BAC transgenic mice conforms to the expected projection pattern of MSNs of the direct pathway.
Gross characteristics of the transplanted M4-BAC-GFP embryonic tissue in the HD model
Single cell suspension prepared from WGE of E14 embryonic M4-BAC-GFP tissue was grafted into the mice with unilateral stri- atal lesions. The lesion depleted a large part of the striatum of the MSN, produced tissue shrinkage as a consequence of the cell loss, and the expansion of the ipsilateral lateral ventricle as described before (Döbrössy and Dunnett, 2005) . The grafted cells, placed within the degenerating striatum were visualized and identified by various staining methods and prompt the following observations: firstly, the transgenic donor cells survived for at least 24 weeks without any immunosuppression; this was as expected following previous allotransplantation studies. Secondly, the presence of the grafted cells was confirmed by general nuclei staining using Cresyl Violet, and by the mature neuronal marker NeuN (Fig. 3A-F) . The excitotoxic lesion depleted the striatum selectively for the MSN and the changes in the striatal cytoarchitecture are clearly detectable. In both, the Cresyl Violet and the NeuN images, the graft is distinguishable from the host, although with the latter stain the lesioned striatum peripheral to the graft is more obvious as it stains specifically neurones. Thirdly, the GFP expression in the M4-BAC-GFP embryonic tissue remained present at 24 weeks post-grafting and permitted unambiguous identification of the transplanted tissue ( Fig. 3G-I) . Fourthly, a large proportion of the graft expressed the selective striatal neuron marker dopamine and cAMP regulated phosphoprotein of 32 kDa, DARPP-32 ( Fig. 3J-L) . Similar to the GFP staining, the DARPP-32 positive neurones were clustered into patches, whilst there were also non-stained areas within the graft. The patch/non-patch staining pattern indicates the heterogeneity within the transplant whose cells originated from striatal M4-BAC-GFP, other striatal neuronal sub-types, and non-striatal cells of the WGE.
Integration of the M4-BAC-GFP graft with the host
The projections of grafted cells extended and ramified extensively into the host tissue ( Fig. 4A-G) . In the periphery of the graft and in the immediate vicinity of the graft-host interface zone, fibres from the transplant extended into the host striatum ( Fig. 4C-F) . Neither in the area close to the core of the graft, nor at more distal regions were GFP positive cell bodies observed indicating that the GFP positive MSNs within the grafts did not themselves migrate from the site of transplantation, but did extend extensive efferent projections. In areas more distant from the site of transplantation, GFP positive stained fibres -but not cell bodies -were observed. The histological data shows that the striatal cells grafted ectopically into the dorsal striatum had the capacity to project downstream to distances up to approximately 2-3 mm and sent connections to an anatomically authentic target area such as the EP (Fig. 4G-I) . By contrast no GFP positive fibres were observed within the major projection zone of the indirect pathway, in the GPe.
Discussion
The study was designed to validate the use of M4-BAC-GFP transgenic animal as tissue donor in cell-based therapy in a rodent model of Huntington's disease (HD). The data supports the conclusions that E14 embryonic WGE tissue, containing predominantly MSN precursor cells, from the M4-BAC-GFP animals (i) can survive the tissue preparation and transplantation procedures, (ii) remains conducive to identification up to 24 weeks post-grafting in the host, and (iii) sends efferent projections into the host striatal tissue and further downstream including to a target of the striatonigral projection, the EP. The study confirms that embryonic striatal tissue from the M4-BAC-GFP transgenic animals represents a novel way to study graft-host interaction in lesion models of HD.
The transgenic animals used as tissue donors in the current study were designed to express the GFP reporter gene under the muscarinic receptor M4 promoter exclusively to MSNs. The adult M4-BAC-GFP transgenic line, along with other lines where GFP expression is associated with either the D1 or D2 promoters, have been described elsewhere (Lu, 2009; Valjent et al., 2009; Day et al., 2006) . However, the use of embryonic tissue from the M4-BAC-GFP animals for grafting into adult hosts has not yet been investigated.
The first important finding of the study was the confirmation that the dissociated cell suspension prepared from the dissected E14 M4-BAC-GFP embryo's WGE survived the procedure, and importantly, continued to express the GFP reporter gene, stably and long-term. There is some evidence that in the M4-BAC-GFP mice GFP expression in the developing forebrain is present already as early as E10.5 (based on images from the Mutant Mouse Regional Resource Centre website, www.mmrrc.org), which coincides with the appearance and formation of the ganglionic eminence. At this stage, neither do the emerging striatal cells project to any of Fig. 4 . The fluorescent and histological observations indicate that projections of graft origin integrated into the host tissue (A and B; white dots represent the interface between the graft and the host). On the periphery of the graft and in the immediate vicinity of the graft-host interface zone, fibres from the transplant extended into the host striatum (C-F). Importantly, the GFP staining also showed the ectopically grafted striatal cells had the capacity to project downstream to distances up to approximately 2-3 mm and send connections to an anatomically authentic target area such as the entopeduncular nucleus (G-I). Scale bars: 500 m (B and C); 250 m (D); 100 m (F and H); 2 mm (G). their eventual targets, nor do they receive afferents as the striatal neurons are just starting to appear around E12 (Bayer, 1984; Marchand and Lajoie, 1986; Olsson et al., 1998) . Such premature expression of GFP under the M4 promoter suggests that the activation of the M4-BAC regulatory elements are context independent and goes someway to explain why the grafted cells continuously expressed the reporter even after the relatively robust procedure of the dissection, single cell preparation and transplantation from an embryonic to an adult environment. It has been previously demonstrated that embryonic striatal cells can reconnect with the host and form appropriate synapses given time (Wictorin, 1992; Clarke et al., 1988a,b; Clarke and Dunnett, 1993) ; however, GFP expression has been observed in the grafts as early as 3-4 weeks despite the absence of interconnectivity of the cells at this time. This observation contrasts with some experimental data showing the importance of the cholinergic environment, such as the density of cholinergic input or choline acetyltransferase activity, to the expression of the cell surface m4 muscarinic receptors on the MSNs (Bernard et al., 1999) . It is possible, but has not been investigated, that in the current study there was a temporary down-regulation and loss of GFP signal for a period immediately following the M4-BAC-GFP tissue grafts.
The second important observation emerging from the present study was that the GFP expression was present even after 24 weeks post transplantation which is essential in long-term experiments and whether the transgenic animal can be used as a tissue donor or not. This time-point was used as it corresponds approximately to the length of a typical grafting study that includes behavioural testing, as well as cellular and morphological analysis. It has been shown that approximately a third of the striatal neurones have already differentiated into MSNs at E14, but a large proportion of the striatal progenitor cells within the cell suspension continues to proliferate post-transplantation (Fricker-Gates et al., 2004) . The peak gestational age when striatal neurones undergo their final division is around E16, and although cellular development of the in situ and the grafted ganglionic eminence cells is probably not identical, clinical data supports that MSN differentiation continues during the post-grafting period leading to the limited expansion of the graft (Capetian et al., 2009) . Good cell survival of grafted embryonic striatal cells has been repeatedly described in previous allotransplantation models of HD Dunnett, 2004, 2008) ; however, the long-term expression of the GFP reporter gene in a BAC transgenic tissue over a period of 6 months after the transplantation has now been confirmed for the first time.
Thirdly, the receptor specific phenotype of the separate subpopulations of MSNs, specified in the embryonic period, appears not only to be sustained long-term but also to respect the maintenance of specific projection patterns in the adult brain, in this case the M4R positive phenotype giving rise to projections via the direct pathway. This could reflect two alternative processes. Either the M4+ phenotype which is specified in the embryo, is retained in the adult and regulates outgrowth of developing axons to respond to the specific environmental cues that guide and direct axon growth via the direct pathway to their appropriate SNr and EP targets. Alternatively, all MSNs within the developing embryo carry the transgenic GFP gene under its M4R promoter, but GFP gene expression is selectively turned on in those MSNs whose axons end up reaching the direct pathway targets. The expression of the M4R gene in some but not all MSNs as early as E10.5 in the developing embryo, prior to the time of transplantation, clearly favours the first alternative, but further studies tracking outgrowth and GFP expression developmentally in striatal grafts are clearly warranted to resolve these two alternative hypotheses.
Finally, and crucially, the grafted tissue showed anatomical integration with the host tissue which was confirmed based on the presence of the GFP positive processes at distances up to 2-3 mm from the core of the graft. Previously, anatomical integration has been studied using xenografts, where murine-to-rat, or human-to-rat grafts allows the identification of the grafts using species-specific markers Wictorin et al., , 1988 ; however, graft rejection of primary tissue is a major obstacle in cross-species transplantation and immunosuppression is required to promote graft survival (Barker and Widner, 2004) . These problems do not arise using mouse BAC-GFP tissue donors grafted into mice hosts. And most importantly tracing of grafted cells is still possible due to the expression of GFP of the donor cells. Interestingly, GFP fibres were observed in the EP to which the MSNs of the direct pathway project in healthy animals. Demonstrating that the dissected, dissociated and transplanted MSNs expressing the appropriate receptors also project to their "authentic" direct pathway anatomical target suggests that the target selection mechanism might be inherent to the neurones as much as it may be guided by external factors.
In conclusion, the data confirm that embryonic striatal tissue from the M4-BAC-GFP mice is a viable and highly beneficial source of tissue for future grafting studies as the cells survive, continuously expresses GFP, and integrate with the host. The combined use of additional lines of BAC animals with unique fluorescent reporter genes expressed in different striatal MSN sub-types will allow further refining of our understanding of graft-induced circuit re-connectivity in models of neurodegenerative disease.
